SYRE · Spyre Therapeutics, Inc. · Executive Compensation
$90.60
+1.89 (+2.13%)
At close · Sep 11
Going-concern doubt
— flagged Aug 4, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We will need to raise additional capital to continue to fund our operations in the future. If we are unable to raise additional capital when needed, we will not be able to continue as a going concern.”View the 10-Q filed Aug 4, 2026
Market Cap
$7.99B
Shares
88.17M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Cameron Turtle | Chief Executive Officer | $6,707,361 |
| Sheldon Sloan | Chief Medical Officer | $2,211,805 |
| Scott Burrows | Chief Financial Officer | $2,192,045 |
| Heidy King-Jones | Chief Legal Officer and Corporate Secretary | $2,192,045 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Sheldon Sloan | Chief Medical Officer | $9,388,740 |
| Cameron Turtle | Chief Executive Officer | $6,960,186 |
| Scott Burrows | Chief Financial Officer | $2,207,366 |
| Heidy King-Jones | Chief Legal Officer and Corporate Secretary | $2,051,909 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Cameron Turtle | Chief Executive Officer | $15,919,545 |
| Jonathan Alspaugh | Former Chief Financial Officer | $8,360,029 |
| Scott Burrows | Chief Financial Officer | $7,551,539 |
| Heidy King-Jones | Chief Legal Officer and Corporate Secretary | $6,588,281 |
| Jeffrey M. Goldberg | Former President and Chief Executive Officer | $830,207 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Anthony G. Quinn | M.B Ch.B, Ph.D. Former President and Chief Executive Officer | $2,392,254 |
| Jeffrey M. Goldberg | Former President and Chief Executive Officer | $1,832,485 |
| Leslie Sloan | Former Chief Operating Officer | $1,087,882 |
| Jonathan Alspaugh | Former Chief Financial Officer | $1,011,840 |
| Jim Kastenmayer | — | $865,785 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Anthony G. Quinn | M.B Ch.B, Ph.D. Former President and Chief Executive Officer | $2,623,186 |
| Leslie Sloan | Former Chief Operating Officer | $1,449,436 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Laurie Stelzer | Class I director | Appointed | 2026-05-29 |
| Cameron Turtle | Class I director | Appointed | 2026-05-29 |
| Mark McKenna | Class I director | Appointed | 2026-05-29 |
| Peter Harwin | Board | Resigned | 2026-05-29 |
Key facts
CIK
1636282
CUSIP
00773J202
13F (30d)
118 filings
117 filers
Visit website
Investor relations